Key facts
- This page summarizes Xia Ding's Form 4 filing for USANA HEALTH SCIENCES INC (USNA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jul 2023, 11:40.
Xia Ding - 27 Jul 2023 Form 4 Insider Report for USANA HEALTH SCIENCES INC (USNA)
- Reporting relationship
- Director
- Issuer ticker
- USNA
- Reported as of
- 27 Jul 2023
- Net transaction value
- -$39,753
- SEC form
- 4
- Accepted by SEC
- 28 Jul 2023, 11:40:29 UTC
- Prior SEC filing
- 26 Jul 2023
- Next SEC filing
- 25 Oct 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Foukas, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Xia Ding filed Form 4 for USANA HEALTH SCIENCES INC (USNA) on 28 Jul 2023.
Change
- Previous filing in this sequence was filed on 26 Jul 2023.
- Current net transaction value: -$39,753.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
USNA
transaction
Common Stock
Sale
- Transaction value
- -$39,753
- Shares
- -606
- Change %
- -30%
- Price
- $65.60
- Shares after
- 1,421
- Date
- 27 Jul 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Weighted average price $65.5994. Price range in multiple transactions was $65.52 to $65.74 inclusively.